(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 9.28% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Mckesson's revenue in 2024 is $308,951,000,000.On average, 3 Wall Street analysts forecast MCK's revenue for 2025 to be $45,762,102,385,447, with the lowest MCK revenue forecast at $43,370,715,599,212, and the highest MCK revenue forecast at $47,099,822,045,704. On average, 6 Wall Street analysts forecast MCK's revenue for 2026 to be $48,133,009,044,051, with the lowest MCK revenue forecast at $45,788,346,200,752, and the highest MCK revenue forecast at $52,660,797,312,895.
In 2027, MCK is forecast to generate $53,049,965,492,752 in revenue, with the lowest revenue forecast at $49,714,216,659,235 and the highest revenue forecast at $56,483,164,336,130.